1. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214–219.
2. Gelfand A. Dogs, doses and devices: FDA’s ambitious plans for computational modeling. Biomedical Computational Review. Fall 2011, pp 20–26. http://biomedicalcomputationreview.org/7/2/10.pdf.
3. Archimedes Inc. Case study: comparative effectiveness analysis. http://www.archimedesmodel.com/sites/default/files/Cost-Effectiveness-Archimedes.pdf. Accessed December 21, 2012.
4. Cray Inc. News release. Cray supercomputers play key role in designing Boeing 787 Dreamliner. http://investors.cray.com/phoenix.zhtml?c=98390&p=irol-newsArticle&ID=1022899. Published July 5, 2007.
5. Parks M. Biggest challenges sponsors face in diabetes trials. Podcast, Applied Clinical Trials Online. http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/article/articleDetail.jsp?id=641256. Published November 12, 2009.